ORLANDO, FL USA (UroToday.com) - Commensurate with improved capabilities and understanding of imaging technology and renal tumor histology, some studies have suggested that papillary renal cell carcinoma Type 1 (T1-pRCC) and Type 2 (T2-pRCC) may be distinguished by their behavior and morphology in imaging studies.

ORLANDO, FL USA (UroToday.com) - In this podium presentation, Dr. Laurence Klotz presented follow-up data of nearly 20 years on a large single center active surveillance cohort which included 840 men with low- or intermediate-risk prostate cancer.

ORLANDO, FL USA (UroToday.com) - In this podium presentation, Dr. Robert Blackwell presented complications with urologic relevance in seen in 888 patients undergoing radiation therapy (RT) for prostate cancer at a single institution between 1992 and 2013.

ORLANDO, FL USA (UroToday.com) - Dr. Christopher Barbieri presented his work evaluating the role of SPOP mutations in prostate cancer. SPOP point mutations were identified in prostate cancer by his group after whole exome sequencing in 2012, but the functional significance of these mutations had yet to be explored.

ORLANDO, FL USA (UroToday.com) - Dr. Ashish M. Kamat presented data his group has been accumulating in an effort to predict response to BCG in patients with non-muscle invasive bladder cancer (NMIBC).

ORLANDO, FL USA (UroToday.com) -

Immune checkpoint inhibitors in CRPC

ORLANDO, FL USA (UroToday.com) -

Temporal heterogeneity and microenvironment dependent to develop marker-driven curative intent treatment strategies

ORLANDO, FL USA (UroToday.com) - Over the last several years, prognostic systemic inflammatory markers such as, erythrocyte sedimentation rate (ESR), platelet count, C-reactive protein (CRP), vascular endothelial growth factors (VEGF), and serum interleukin-6 levels (IL-6), related to RCC outcomes have been described.

ORLANDO, FL USA (UroToday.com) - The treatment plans patients receive from their physicians because of renal stones is not always followed through due to changes in patients’ attitudes over time. Kristina L Penniston and colleagues assessed patients’ experiences with compliance with preventative regimens for treatment of renal stones.

ORLANDO, FL USA (UroToday.com) - Calcium phosphate stones are more common in basic urine pH. Thus, there is concern that the potassium citrate (KCIT) may increase the formation of this subtype of renal stones. As a result, Sara L Best and colleagues wanted to evaluate stone composition and 24-h urinary parameters in patients on KCIT.